Global Bone Biopsy Market Research Report: Information by Type (Needle Biopsy and Open Biopsy), Guidance (MRI Guided and CT Guided), and End Users (Hospitals and Clinics, Surgical Centers, and Others), and Region (Americas, Europe, Asia-Pacific, Middle East & Africa)— Forecast till 2027
ID: MRFR/MED/3898-HCR | | Region: Global | 110 pages
Market Scenario
The global bone biopsy market is expected to register ~4.5% CAGR during the forecast period of 2019 to 2025 and is expected to reach USD 718 million by 2025. Bone biopsy is a procedure, in which a sample of cells or tissues are collected from the bone for examination. The procedure is generally performed to confirm the presence of bone cancer, investigation of a lesion, and identify the cause of inflammation or infection. Furthermore, factors such as stringent regulatory policies, product recall, and others are hampering the growth of the market.
Segmentation
The global bone biopsy market is segmented on type, guidance, end users, and region. The global market for bone biopsy, by type, is segmented into needle biopsy and open biopsy. Based on guidance, the global market is divided into guided and non-guided, where the guided segment is further sub-segmented into MRI-guided and CT-guided. The guided segment is expected to hold the highest market share due to the clinical advantages over its non-guided counterparts. The end user segment consists of hospitals & clinics, specialty centers, and others. The hospitals & clinics segment is expected to dominate the market due to the increasing number of hospitals. In the current scope of the study, the segments mentioned above are covered under four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bone biopsy market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European bone biopsy market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The bone biopsy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone biopsy market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Some of the key players operating in the global bone biopsy market are BD (US), B. Braun Melsungen AG (Germany), Cook (US), GENERAL ELECTRIC COMPANY (US), ARGON MEDICAL (US), MERMAID MEDICAL A/S (Denmark), Ranfac Corp. (US), Kimal (UK), and Remington Medical (US).
Regional Market Summary Global Bone Biopsy Market Share (%), by Region, 2018 
Sources: MRFR Analysis The Americas dominated the bone biopsy market owing to the high prevalence of bone cancer and presence of major manufacturers in the region. In 2018, Europe accounted for the second-largest market share. However, Asia-Pacific is expected to register the fastest CAGR due to increasing awareness regarding bone cancer and growing healthcare infrastructure. On the other hand, the Middle East & Africa is expected to hold the least share in the bone biopsy market due to limited access to health facilities and lack of awareness regarding health management.
Global Bone Biopsy Market, by Type
- Needle Biopsy
- Open Biopsy
Global Bone Biopsy Market, by Guidance
- GuidedMRI-Guided
- CT-Guided
- Non-Guided
Global Bone Biopsy Market, by End User
- Hospitals and Clinics
- Surgical Centers
- Others
Global Bone Biopsy Market, by Region
- Americas
- North America
- US
- Canada
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Medical device manufacturers
- Government research institutes
- Academic institutes and universities
- Venture capitalists
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 718 million (2025) |
| CAGR | 4.5% (2020-2027) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | type, guidance, end users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | BD (US), B. Braun Melsungen AG (Germany), Cook (US), GENERAL ELECTRIC COMPANY (US), ARGON MEDICAL (US), MERMAID MEDICAL A/S (Denmark), Ranfac Corp. (US), Kimal (UK), and Remington Medical (US). |
| Key Market Opportunities |
|
| Key Market Drivers | high prevalence of bone cancer |
Frequently Asked Questions (FAQ) :
Global bone biopsy market is expected to expand at 4.5% CAGR from 2019 to 2025.
Global bone biopsy market can touch USD 718 million by 2025.
Rising prevalence of bone cancer is the primary driver of the global bone biopsy market.
Recall of products and strict regulatory policies are factors expected to impede the global gastric bypass market growth.
The Americas is expected to dominate in the global bone biopsy market till 2023 due to high prevalence of bone cancer.
GENERAL ELECTRIC COMPANY, Cook, Kimal, Remington Medical, ARGON MEDICAL, BD, B. Braun Melsungen AG, Ranfac Corp., and MERMAID MEDICAL A/S are prominent players of the global bone biopsy market.
Table Of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope Of The Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power Of Suppliers
5.1.2. Bargaining Power Of Buyers
5.1.3. Threat Of New Entrants
5.1.4. Threat Of Substitutes
5.1.5. Intensity Of Rivalry
5.2. Value Chain Analysis
6. GLOBAL BONE BIOPSY MARKET, BY TYPE
6.1. Overview
6.2. Needle Biopsy
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
6.3. Open Biopsy
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
7. GLOBAL BONE BIOPSY MARKET, BY GUIDANCE
7.1. Overview
7.2. Guided
7.2.1. MRI Guided
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
7.2.2. CT Guided
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
7.3. Non-Guided
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
8. GLOBAL BONE BIOPSY MARKET, BY END USER
8.1. Overview
8.2. Hospitals & Clinics
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
8.3. Surgical Centers
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
8.4. Others
Market Estimates & Forecast, By Region, 2020–2027
Market Estimates & Forecast, By Country, 2020–2027
9. GLOBAL BONE BIOPSY MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest Of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest Of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1.1. Overview
10.1.2. Competitive Analysis
11. COMPANY PROFILES
11.1. BD
11.1.1. Company Overview
11.1.2. Product Type Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. B. Braun Melsungen AG
11.2.1. Company Overview
11.2.2. Product Type Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Cook
11.3.1. Company Overview
11.3.2. Product Type Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. GENERAL ELECTRIC COMPANY
11.4.1. Company Overview
11.4.2. Product Type Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. ARGON MEDICAL
11.5.1. Company Overview
11.5.2. Product Type Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. MERMAID MEDICAL A/S
11.6.1. Company Overview
11.6.2. Product Type Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Ranfac Corp.
11.7.1. Company Overview
11.7.2. Product Type Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Kimal
11.8.1. Company Overview
11.8.2. Product Type Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Remington Medical
11.9.1. Company Overview
11.9.2. Product Type Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Others
11.10.1. Company Overview
11.10.2. Product Type Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BONE BIOPSY MARKET SYNOPSIS, 2020–2027
TABLE 2 GLOBAL BONE BIOPSY MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)
TABLE 3 GLOBAL BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 4 GLOBAL BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 5 GLOBAL BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 6 GLOBAL BONE BIOPSY MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 7 NORTH AMERICA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 8 NORTH AMERICA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 10 US: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 11 US: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 12 US: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 13 CANADA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 CANADA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 15 CANADA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 16 LATIN AMERICA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 LATIN AMERICA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 18 LATIN AMERICA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 19 EUROPE: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 20 EUROPE: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 21 EUROPE: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BONE BIOPSY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BONE BIOPSY MARKET
FIGURE 4 GLOBAL BONE BIOPSY MARKET SHARE, BY TYPE, 2018 (%)
FIGURE 5 GLOBAL BONE BIOPSY MARKET SHARE, BY GUIDANCE, 2018 (%)
FIGURE 6 GLOBAL BONE BIOPSY MARKET SHARE, BY END USER, 2018 (%)
FIGURE 7 GLOBAL BONE BIOPSY MARKET SHARE, BY REGION, 2018 (%)
FIGURE 8 AMERICAS: BONE BIOPSY MARKET SHARE BY REGION, 2018 (%)
FIGURE 9 NORTH AMERICA: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 10 EUROPE: BONE BIOPSY MARKET SHARE, BY REGION, 2018 (%)
FIGURE 11 WESTERN EUROPE: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 12 ASIA-PACIFIC: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 13 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 14 GLOBAL BONE BIOPSY MARKET: COMPANY SHARE ANALYSIS, 2018 (%)
FIGURE 15 BD: KEY FINANCIALS
FIGURE 16 BD: SEGMENTAL REVENUE
FIGURE 17 BD: REGIONAL REVENUE
FIGURE 18 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 19 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 20 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE
FIGURE 21 COOK: KEY FINANCIALS
FIGURE 22 COOK: SEGMENTAL REVENUE
FIGURE 23 COOK: REGIONAL REVENUE
FIGURE 24 GENERAL ELECTRIC COMPANY: KEY FINANCIALS
FIGURE 25 GENERAL ELECTRIC COMPANY: SEGMENTAL REVENUE
FIGURE 26 GENERAL ELECTRIC COMPANY: REGIONAL REVENUE
FIGURE 27 ARGON MEDICAL: KEY FINANCIALS
FIGURE 28 ARGON MEDICAL: SEGMENTAL REVENUE
FIGURE 29 ARGON MEDICAL: REGIONAL REVENUE
FIGURE 30 MERMAID MEDICAL A/S: KEY FINANCIALS
FIGURE 31 MERMAID MEDICAL A/S: SEGMENTAL REVENUE
FIGURE 32 MERMAID MEDICAL A/S: REGIONAL REVENUE
FIGURE 33 RANFAC CORP.: KEY FINANCIALS
FIGURE 34 RANFAC CORP.: SEGMENTAL REVENUE
FIGURE 35 RANFAC CORP.: REGIONAL REVENUE
FIGURE 36 KIMAL: KEY FINANCIALS
FIGURE 37 KIMAL: SEGMENTAL REVENUE
FIGURE 38 KIMAL: REGIONAL REVENUE
FIGURE 39 REMINGTON MEDICAL: KEY FINANCIALS
FIGURE 40 REMINGTON MEDICAL: SEGMENTAL REVENUE
FIGURE 41 REMINGTON MEDICAL: REGIONAL REVENUE